| 0 |
OPTIC DISC DRUSEN |
1 |
0.0159 |
| 1 |
MIDDLE CEREBRAL ARTERY STROKE |
1 |
0.0088 |
| 2 |
RETINAL DRUSEN |
1 |
0.0061 |
| 3 |
VITREOUS DEGENERATION |
1 |
0.0061 |
| 4 |
BORDERLINE GLAUCOMA |
1 |
0.0054 |
| 5 |
RETINAL OCCLUSIVE VASCULITIS |
1 |
0.0045 |
| 6 |
EPIRETINAL MEMBRANE |
1 |
0.0036 |
| 7 |
RETINOPATHY HYPERTENSIVE |
1 |
0.0033 |
| 8 |
RETINAL VASCULAR DISORDER |
1 |
0.0017 |
| 9 |
CATARACT NUCLEAR |
1 |
0.0015 |
| 10 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
2 |
0.0014 |
| 11 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 12 |
CHOROIDAL NEOVASCULARISATION |
1 |
0.0012 |
| 13 |
DEVICE LOOSENING |
1 |
0.0012 |
| 14 |
PUNCTATE KERATITIS |
1 |
0.0011 |
| 15 |
METAMORPHOPSIA |
2 |
0.0011 |
| 16 |
RETINAL EXUDATES |
1 |
0.0011 |
| 17 |
ENDOPHTHALMITIS |
6 |
0.0010 |
| 18 |
ONYCHALGIA |
1 |
0.0010 |
| 19 |
REFUSAL OF TREATMENT BY PATIENT |
5 |
0.0008 |
| 20 |
CORNEAL ABRASION |
1 |
0.0007 |
| 21 |
MEDICAL PROCEDURE |
1 |
0.0006 |
| 22 |
RETINITIS |
1 |
0.0006 |
| 23 |
VITRITIS |
1 |
0.0005 |
| 24 |
DEVICE PHYSICAL PROPERTY ISSUE |
4 |
0.0005 |
| 25 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 26 |
HYPERAEMIA |
1 |
0.0005 |
| 27 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
3 |
0.0004 |
| 28 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 29 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 30 |
THROMBOSIS IN DEVICE |
1 |
0.0003 |
| 31 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 32 |
UVEITIS |
4 |
0.0003 |
| 33 |
MACULOPATHY |
1 |
0.0003 |
| 34 |
RETINOPATHY |
1 |
0.0003 |
| 35 |
HORDEOLUM |
1 |
0.0002 |
| 36 |
BLINDNESS UNILATERAL |
3 |
0.0002 |
| 37 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 38 |
INTERCEPTED PRODUCT PREPARATION ERROR |
2 |
0.0002 |
| 39 |
SCOLIOSIS |
1 |
0.0002 |
| 40 |
HERPES SIMPLEX |
1 |
0.0002 |
| 41 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 42 |
ONYCHOCLASIS |
1 |
0.0001 |
| 43 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 44 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 45 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 46 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 47 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 48 |
FACIAL PAIN |
1 |
0.0001 |
| 49 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 50 |
TREATMENT FAILURE |
9 |
0.0001 |
| 51 |
EYE PAIN |
6 |
0.0001 |
| 52 |
EYE INFLAMMATION |
1 |
0.0001 |
| 53 |
NEEDLE ISSUE |
3 |
0.0001 |
| 54 |
EYELID OEDEMA |
1 |
0.0001 |
| 55 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 56 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 57 |
DIALYSIS |
1 |
0.0001 |
| 58 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 59 |
LYMPHOMA |
1 |
0.0001 |
| 60 |
EYE DISORDER |
2 |
0.0001 |
| 61 |
DRY EYE |
3 |
0.0001 |
| 62 |
DEVICE USE ERROR |
2 |
0.0001 |
| 63 |
PHOTOPHOBIA |
1 |
0.0001 |
| 64 |
GASTRIC ULCER |
1 |
0.0001 |
| 65 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 66 |
DISABILITY |
1 |
0.0001 |
| 67 |
SNEEZING |
1 |
0.0000 |
| 68 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 69 |
PRESYNCOPE |
1 |
0.0000 |
| 70 |
DIABETES MELLITUS |
3 |
0.0000 |
| 71 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 72 |
NERVOUSNESS |
2 |
0.0000 |
| 73 |
DEAFNESS |
1 |
0.0000 |
| 74 |
HAEMOPTYSIS |
1 |
0.0000 |
| 75 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 76 |
EYE IRRITATION |
2 |
0.0000 |
| 77 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 78 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 79 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 80 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 81 |
GAIT INABILITY |
1 |
0.0000 |
| 82 |
BLINDNESS |
1 |
0.0000 |
| 83 |
POLLAKIURIA |
1 |
0.0000 |
| 84 |
VISION BLURRED |
3 |
0.0000 |
| 85 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 86 |
COUGH |
6 |
0.0000 |
| 87 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 88 |
AGGRESSION |
1 |
0.0000 |
| 89 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 90 |
INFLAMMATION |
1 |
0.0000 |
| 91 |
DEPRESSED MOOD |
1 |
0.0000 |
| 92 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 93 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 94 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 95 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 96 |
AMNESIA |
1 |
0.0000 |
| 97 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 98 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 99 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 100 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 101 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 102 |
ADVERSE EVENT |
1 |
0.0000 |
| 103 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 104 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 105 |
ILLNESS |
1 |
0.0000 |
| 106 |
ASTHMA |
1 |
0.0000 |
| 107 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 108 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 109 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 110 |
OFF LABEL USE |
6 |
0.0000 |
| 111 |
HYPOAESTHESIA |
1 |
0.0000 |
| 112 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 113 |
HEADACHE |
4 |
0.0000 |
| 114 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 115 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 116 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 117 |
MUSCLE SPASMS |
1 |
0.0000 |
| 118 |
CHEST PAIN |
1 |
0.0000 |
| 119 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 120 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 121 |
HYPERTENSION |
1 |
0.0000 |
| 122 |
DIARRHOEA |
3 |
0.0000 |
| 123 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 124 |
BACK PAIN |
1 |
0.0000 |
| 125 |
FEELING ABNORMAL |
1 |
0.0000 |
| 126 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 127 |
FATIGUE |
3 |
0.0000 |
| 128 |
WEIGHT DECREASED |
1 |
0.0000 |
| 129 |
DYSPNOEA |
2 |
0.0000 |
| 130 |
ANXIETY |
1 |
0.0000 |
| 131 |
DEATH |
3 |
0.0000 |
| 132 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 133 |
PNEUMONIA |
1 |
0.0000 |
| 134 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 135 |
ASTHENIA |
1 |
0.0000 |
| 136 |
ARTHRALGIA |
1 |
0.0000 |
| 137 |
DIZZINESS |
1 |
0.0000 |